Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|7|735-742

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.7, 2015-07, pp. : 735-742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and Design of the ‘MITOCARE’ Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

By  

Cardiology, Vol. 123, Iss. 4, 2012-11 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

By Cooper Cyrus   Reginster Jean-Yves   Chapurlat Roland   Christiansen Claus   Genant Harry   Bellamy Nicholas   Bensen William   Navarro Federico   Badurski Janusz   Nasonov Evgeny   Chevalier Xavier   Sambrook Philip N.  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 231-239

Informa Healthcare

Access to resources Recommend Favorite

Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF‐Wii study; a multicentre randomized controlled trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 743-748

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

By Holme Ingar   Aastveit Are   Hammar Niklas   Jungner Ingmar   Walldius Goran  

Annals of Medicine, Vol. 41, Iss. 7, 2009-01 ,pp. : 522-532

Informa Healthcare

Access to resources Recommend Favorite

Design of Randomized, double‐blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE‐SPECT ESUS)

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 8, 2015-12 ,pp. : 1309-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite